Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

14.3%

1 terminated/withdrawn out of 7 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

67%

2 of 3 completed trials have results

Key Signals

2 recruiting2 with results

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 1

2(28.6%)

Early Phase 1

1(14.3%)

7Total

N/A(4)

Phase 1(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05895305Early Phase 1Active Not Recruiting

Paclitaxel-Coated Pulmonary Balloon for the Treatment of Benign Airway Stenosis

Role: collaborator

NCT03055819Not ApplicableTerminated

Evaluation of Patient and Physician Satisfaction With the Zift eLevatIon of Facial Tissue Clinical Study

Role: collaborator

NCT04232774Not ApplicableCompleted

Neurotronic Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

Role: collaborator

NCT05369065Phase 1Recruiting

Ablation of Arteries for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

Role: collaborator

NCT05363761Phase 1Recruiting

Arterial Ablation for the Treatment of Type 2 Diabetes Mellitus and Its Comorbidities

Role: collaborator

NCT03635190Not ApplicableCompleted

Evaluation of the FreedomFlow™ Orbital Atherectomy System to Treat Peripheral Artery Disease

Role: collaborator

NCT03365154Not ApplicableCompleted

Feasibility Clinical Trial of the Cardio Flow Orbital Atherectomy System to Treat Peripheral Artery Disease (PAD)

Role: collaborator

All 7 trials loaded